Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia Corporate presentation – January 2020 de adocia

Latest Press Releases

2020/01/10Half year report on Adocia’s liquidity agreement with Kepler Capital Markets
2020/01/07Number of shares and voting rights of ADOCIA as of December 31, 2019

All Press releases

Next events

19-22 February, 2020 Advanced Technologies and Treatment for Diabetes (ATTD), Madrid, Spain - ATTD 2020 will showcase the latest, world-changing, innovations and research in Technologies & Treatments for Diabetes.

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

East-West CEO, the symposium dedicated to investment in health sector

Biotech Agora: Find the video of Adocia Presentation